1. Home
  2. FSLR vs HOLX Comparison

FSLR vs HOLX Comparison

Compare FSLR & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Solar Inc.

FSLR

First Solar Inc.

HOLD

Current Price

$198.04

Market Cap

20.7B

Sector

Technology

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$76.02

Market Cap

16.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSLR
HOLX
Founded
1999
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical Electronics
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
16.9B
IPO Year
2006
1995

Fundamental Metrics

Financial Performance
Metric
FSLR
HOLX
Price
$198.04
$76.02
Analyst Decision
Buy
Hold
Analyst Count
27
13
Target Price
$236.42
$77.89
AVG Volume (30 Days)
1.8M
20.9M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
18.22
N/A
EPS
14.21
0.79
Revenue
$5,219,376,000.00
$4,100,500,000.00
Revenue This Year
$1.43
$4.74
Revenue Next Year
$16.77
$5.03
P/E Ratio
$13.64
$96.23
Revenue Growth
24.09
1.74
52 Week Low
$119.09
$51.90
52 Week High
$285.99
$76.07

Technical Indicators

Market Signals
Indicator
FSLR
HOLX
Relative Strength Index (RSI) 51.90 69.09
Support Level $196.80 $75.10
Resistance Level $212.10 N/A
Average True Range (ATR) 8.18 0.19
MACD 0.68 0.03
Stochastic Oscillator 51.02 95.19

Price Performance

Historical Comparison
FSLR
HOLX

About FSLR First Solar Inc.

First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: